tradingkey.logo

Artivion Inc

AORT
46.127USD
+0.437+0.96%
Horarios del mercado ETCotizaciones retrasadas 15 min
2.17BCap. mercado
PérdidaP/E TTM

Más Datos de Artivion Inc Compañía

Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.

Información de Artivion Inc

Símbolo de cotizaciónAORT
Nombre de la empresaArtivion Inc
Fecha de salida a bolsaFeb 12, 1993
Director ejecutivoMr. James Patrick (Pat) Mackin
Número de empleados1600
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 12
Dirección1655 Roberts Boulevard N W
CiudadKENNESAW
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal30144
Teléfono17704193355
Sitio Webhttps://artivion.com/
Símbolo de cotizaciónAORT
Fecha de salida a bolsaFeb 12, 1993
Director ejecutivoMr. James Patrick (Pat) Mackin

Ejecutivos de Artivion Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
--
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
--
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+10.15%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+13.32%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
48.71K
--
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-21.64%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
--
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
--
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Aortic stent grafts
39.84M
35.27%
On X
25.57M
22.64%
Preservation Services
25.53M
22.60%
Bio Glue
19.29M
17.07%
Surgical sealants
19.29M
17.07%
Other
2.74M
2.43%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Aortic stent grafts
39.84M
35.27%
On X
25.57M
22.64%
Preservation Services
25.53M
22.60%
Bio Glue
19.29M
17.07%
Surgical sealants
19.29M
17.07%
Other
2.74M
2.43%

Estadísticas de accionistas

Actualizado: dom., 17 de ago
Actualizado: dom., 17 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.75%
Macquarie Investment Management
6.27%
Perceptive Advisors LLC
5.92%
The Vanguard Group, Inc.
5.91%
Fidelity Management & Research Company LLC
4.66%
Otro
65.50%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.75%
Macquarie Investment Management
6.27%
Perceptive Advisors LLC
5.92%
The Vanguard Group, Inc.
5.91%
Fidelity Management & Research Company LLC
4.66%
Otro
65.50%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
50.49%
Investment Advisor/Hedge Fund
28.14%
Private Equity
5.92%
Individual Investor
4.71%
Hedge Fund
2.80%
Research Firm
1.29%
Pension Fund
0.94%
Bank and Trust
0.38%
Venture Capital
0.11%
Otro
5.23%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
392
42.59M
90.27%
-124.80K
2025Q2
391
44.35M
103.59%
+1.98M
2025Q1
402
44.36M
103.89%
+1.66M
2024Q4
380
41.09M
97.75%
+880.04K
2024Q3
367
38.98M
93.02%
-790.24K
2024Q2
349
38.52M
92.17%
-784.32K
2024Q1
347
38.26M
91.68%
-2.02M
2023Q4
342
37.08M
90.20%
-1.57M
2023Q3
339
37.01M
90.02%
-1.95M
2023Q2
331
37.22M
87.77%
-1.77M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
5.54M
11.75%
-205.09K
-3.57%
Jun 30, 2025
Macquarie Investment Management
2.96M
6.27%
+52.54K
+1.81%
Jun 30, 2025
Perceptive Advisors LLC
2.79M
5.92%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
2.79M
5.91%
+16.34K
+0.59%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.20M
4.66%
-584.24K
-21.00%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
1.93M
4.09%
-9.84K
-0.51%
Jun 30, 2025
Juniper Investment Company, LLC
1.86M
3.95%
-229.50K
-10.96%
Aug 08, 2025
Wellington Management Company, LLP
1.71M
3.63%
-13.99K
-0.81%
Jun 30, 2025
State Street Investment Management (US)
1.51M
3.21%
-17.10K
-1.12%
Jun 30, 2025
Fred Alger Management, LLC
1.35M
2.86%
+1.23M
+1018.31%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
AAM Sawgrass US Small Cap Quality Growth ETF
3.92%
Unusual Whales Subversive Democratic Trading ETF
3.39%
ROBO Global Healthcare Technology & Innovation ETF
1.73%
SPDR S&P Health Care Equipment ETF
1.49%
Invesco S&P SmallCap Health Care ETF
1.12%
Invesco Dorsey Wright Healthcare Momentum ETF
0.77%
First Trust Small Cap Growth AlphaDEX Fund
0.68%
Invesco S&P SmallCap 600 Pure Growth ETF
0.61%
Invesco Dorsey Wright SmallCap Momentum ETF
0.39%
iShares Micro-Cap ETF
0.34%
Ver más
AAM Sawgrass US Small Cap Quality Growth ETF
Proporción3.92%
Unusual Whales Subversive Democratic Trading ETF
Proporción3.39%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.73%
SPDR S&P Health Care Equipment ETF
Proporción1.49%
Invesco S&P SmallCap Health Care ETF
Proporción1.12%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción0.77%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.68%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción0.61%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporción0.39%
iShares Micro-Cap ETF
Proporción0.34%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI